Article: BRIEFING - ASIA HEALTH - JULY 20, 2007.

Article: Drug compound leads to death of ovarian cancer ...
M2 Presswire;  April 16, 2008 ;     617 words ...M2 PRESSWIRE-16 April 2008-Yale University: Drug compound leads to death of ovarian cancer cells resistant to ... scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells ...

Article: OFFICIALS: `DRUG COMPOUND' RAIDED IN EASTERN COUNTY
Herald-News (Joliet, IL);  June 7, 1997 ;     441 words ...Will Township -- Police confiscated thousands of dollars of drugs and weapons after raiding a suspected "drug compound" in a remote unincorporated area between Monee and Peotone, authorities said. A resident of the home in the 4800 block of ...

Article: Sequella Lead Drug Compound SQ109 Receives Orphan ...
PR Newswire;  October 22, 2007 ;     700+ words ... ... S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) independently reviewed Sequella lead drug compound, SQ109, and both agencies granted SQ109 orphan drug status for the treatment of tuberculosis. SQ109 shows excellent in ...

Article: Immunosyn garners expanded rights to drug ...
San Diego Business Journal;  November 5, 2007 ;     672 words ...Immunosyn Garners Expanded Rights To Drug Compound: An amended license agreement between Immunosyn Corp. and its largest shareholder, Argyll Biotechnologies LLC, both based in ...

Article: Seikagaku, Discovery Partners International Identify Drug ...
JCNN News Summaries - Japan Corporate News Network;  November 11, 2005 ;     308 words ...Tokyo, Nov 11, 2005 - (JCN) - Seikagaku has identified several drug compound candidates that target sugar chain enzymes, in collaboration with its research partner Discovery Partners International (DPI ...

Article: Drug compound thought to enhance brain functions to ...
Clinical Trials Week;  October 4, 2004 ;     541 words ...2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Former President Ronald Reagan's fight with Alzheimer helped raise public awareness of the disease that not only robs an individual's intellectual activity but also affects the families caring for loved ones with the affliction. Alzheimers disease takes

Article: Drug compound selected as candidate for treatment ...
Drug Week;  October 24, 2003 ;     700+ words ...2003 OCT 24 - (NewsRx.com & NewsRx.net) -- Cytochroma, Inc., announced that it has selected CTA018 as a drug candidate for the treatment of mild-to-moderate psoriasis. "We are very excited to announce the advancement of CTA018 as a pre-IND candidate," stated Robert Foldes, president & CEO.